About this Research Topic
In the realm of pediatric healthcare, managing infectious diseases represents a pivotal challenge, given the distinctive physiological responses and developmental considerations unique to children. This Research Topic is dedicated to the comprehensive examination of diagnosis, prevention, and treatment strategies for key infectious diseases that significantly impact the pediatric population. It encompasses in-depth analyses of influenza, respiratory syncytial virus (RSV), community-acquired pneumonia, COVID-19, and herpes zoster—illnesses that, while broadly affecting various age groups, have unique manifestations and management challenges in children.
Influenza and RSV are leading causes of severe respiratory infections among children, necessitating ongoing research into more effective vaccination strategies and antiviral treatments tailored to the pediatric population. Community-acquired pneumonia continues to be a common cause of morbidity in children worldwide, requiring continual refinement in diagnostic techniques and treatment protocols, particularly in the face of evolving bacterial resistance patterns. The issue also delves into the complexities of managing COVID-19 in children, including the nuances of vaccine responses and long-term sequelae of the infection. Herpes zoster, though rarer in children, poses unique management challenges, especially in immunocompromised populations, underscoring the need for better preventive measures and therapeutic approaches.
This Research Topic aims to gather the latest research and insights from leading experts to advance the understanding of these infectious diseases in children, aiming to enhance clinical outcomes through innovative and evidence-based practices.
The primary goal of this Research Topic is to address the ongoing challenges and advancements in managing infectious diseases in children, with a focus on influenza, RSV, community-acquired pneumonia, COVID-19, and herpes zoster. As these diseases continue to significantly impact child health, this special issue aims to synthesize and disseminate cutting-edge research that enhances diagnostic accuracy, optimizes preventive strategies, and refines treatment protocols. By consolidating current knowledge and highlighting recent innovations, this issue seeks to equip healthcare professionals with the tools necessary to improve outcomes and reduce the burden of these infectious diseases on children and the wider community. Through comprehensive reviews and original studies, we aim to foster a deeper understanding of these complex diseases and contribute to the global effort in pediatric healthcare improvement.
● Prevention and treatment of influenza in children
● Diagnosis, prevention, and treatment of respiratory syncytial virus in children
● Diagnosis, prevention, and treatment of community-acquired pneumonia in children
● Diagnosis, prevention, and treatment of COVID-19 in children
● Prevention and treatment of herpes zoster in children
Influenza and RSV are leading causes of severe respiratory infections among children, necessitating ongoing research into more effective vaccination strategies and antiviral treatments tailored to the pediatric population. Community-acquired pneumonia continues to be a common cause of morbidity in children worldwide, requiring continual refinement in diagnostic techniques and treatment protocols, particularly in the face of evolving bacterial resistance patterns. The issue also delves into the complexities of managing COVID-19 in children, including the nuances of vaccine responses and long-term sequelae of the infection. Herpes zoster, though rarer in children, poses unique management challenges, especially in immunocompromised populations, underscoring the need for better preventive measures and therapeutic approaches.
This Research Topic aims to gather the latest research and insights from leading experts to advance the understanding of these infectious diseases in children, aiming to enhance clinical outcomes through innovative and evidence-based practices.
The primary goal of this Research Topic is to address the ongoing challenges and advancements in managing infectious diseases in children, with a focus on influenza, RSV, community-acquired pneumonia, COVID-19, and herpes zoster. As these diseases continue to significantly impact child health, this special issue aims to synthesize and disseminate cutting-edge research that enhances diagnostic accuracy, optimizes preventive strategies, and refines treatment protocols. By consolidating current knowledge and highlighting recent innovations, this issue seeks to equip healthcare professionals with the tools necessary to improve outcomes and reduce the burden of these infectious diseases on children and the wider community. Through comprehensive reviews and original studies, we aim to foster a deeper understanding of these complex diseases and contribute to the global effort in pediatric healthcare improvement.
● Prevention and treatment of influenza in children
● Diagnosis, prevention, and treatment of respiratory syncytial virus in children
● Diagnosis, prevention, and treatment of community-acquired pneumonia in children
● Diagnosis, prevention, and treatment of COVID-19 in children
● Prevention and treatment of herpes zoster in children
Keywords: Children, influenza, respiratory syncytial virus, community-acquired pneumonia, COVID-19, herpes zoster
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
